{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:05:35Z","timestamp":1767099935755,"version":"3.48.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hunan Innovative Province Construction Special Project","award":["2025JJ81137"],"award-info":[{"award-number":["2025JJ81137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04832-2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:47:29Z","timestamp":1764078449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PBX1 promotes osteoporosis by upregulating HMGB1 to suppress osteogenic differentiation of bone marrow mesenchymal stem cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"4832_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01287-w","author":"N Fuggle","year":"2025","unstructured":"Fuggle N, Rizzoli R, Beaudart C, Cortet B, Curtis EM, Hiligsmann M, et al. Parathyroid hormone receptor agonists in the management of osteoporosis. Nat Rev Rheumatol. 2025. https:\/\/doi.org\/10.1038\/s41584-025-01287-w.","journal-title":"Nat Rev Rheumatol"},{"key":"4832_CR2","doi-asserted-by":"publisher","first-page":"e87436","DOI":"10.7759\/cureus.87436","volume":"17","author":"F Zurel","year":"2025","unstructured":"Zurel F, Bux H, Diveli A, Rashid Z. Genetic influences and targeted treatments in osteoporosis: a systematic review. Cureus. 2025;17:e87436. https:\/\/doi.org\/10.7759\/cureus.87436.","journal-title":"Cureus"},{"key":"4832_CR3","doi-asserted-by":"publisher","first-page":"e081250","DOI":"10.1136\/bmj-2024-081250","volume":"390","author":"CWS Hoong","year":"2025","unstructured":"Hoong CWS, Saul D, Khosla S, Sfeir JG. Advances in the management of osteoporosis. BMJ. 2025;390:e081250. https:\/\/doi.org\/10.1136\/bmj-2024-081250.","journal-title":"BMJ"},{"key":"4832_CR4","doi-asserted-by":"publisher","first-page":"103804","DOI":"10.1016\/j.redox.2025.103804","volume":"86","author":"Y Li","year":"2025","unstructured":"Li Y, Yang Y, Xia D, Fang Y, Tang C, Yu J, et al. Nrf2\/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment. Redox Biol. 2025;86:103804. https:\/\/doi.org\/10.1016\/j.redox.2025.103804.","journal-title":"Redox Biol"},{"key":"4832_CR5","doi-asserted-by":"publisher","first-page":"1586623","DOI":"10.3389\/fnut.2025.1586623","volume":"12","author":"H-T Jiao","year":"2025","unstructured":"Jiao H-T, Yue Y-S, Yuan S, Zhou X-J, Li C. Is it advisable for Asians to drink milk, especially those at risk of osteoporosis? Front Nutr. 2025;12:1586623. https:\/\/doi.org\/10.3389\/fnut.2025.1586623.","journal-title":"Front Nutr"},{"key":"4832_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12967-025-06849-w","volume":"23","author":"F Chen","year":"2025","unstructured":"Chen F, Gu M, Xu H, Zhou S, Shen Z, Li X, et al. Chronic intermittent hypoxia impairs BM-MSC osteogenesis and long bone growth through regulating histone lactylation. J Transl Med. 2025;23:845. https:\/\/doi.org\/10.1186\/s12967-025-06849-w.","journal-title":"J Transl Med"},{"key":"4832_CR7","doi-asserted-by":"publisher","first-page":"1372873","DOI":"10.3389\/fcell.2024.1372873","volume":"12","author":"L Crisafulli","year":"2024","unstructured":"Crisafulli L, Brindisi M, Liturri MG, Sobacchi C, Ficara F. PBX1: a TALE of two seasons-key roles during development and in cancer. Front Cell Dev Biol. 2024;12:1372873. https:\/\/doi.org\/10.3389\/fcell.2024.1372873.","journal-title":"Front Cell Dev Biol"},{"key":"4832_CR8","doi-asserted-by":"publisher","first-page":"189085","DOI":"10.1016\/j.bbcan.2024.189085","volume":"1879","author":"T-W Kao","year":"2024","unstructured":"Kao T-W, Chen H-H, Lin J, Wang T-L, Shen Y-A. PBX1 as a novel master regulator in cancer: its regulation, molecular biology, and therapeutic applications. Biochim Biophys Acta Rev Cancer. 2024;1879:189085. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189085.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4832_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41420-025-02472-2","volume":"11","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang Y, Xu C, Li Q, Ji P, Liu H, et al. MGP regulates the adipogenic differentiation of mesenchymal stem cells in osteoporosis via the Ca2+\/CaMKII\/RIP140\/FABP3 axis. Cell Death Discov. 2025;11:166. https:\/\/doi.org\/10.1038\/s41420-025-02472-2.","journal-title":"Cell Death Discov"},{"key":"4832_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000324790","volume":"194","author":"JAR Gordon","year":"2011","unstructured":"Gordon JAR, Hassan MQ, Koss M, Montecino M, Selleri L, van Wijnen AJ, et al. Epigenetic regulation of early osteogenesis and mineralized tissue formation by a HOXA10-PBX1-associated complex. Cells Tissues Organs. 2011;194:146\u201350. https:\/\/doi.org\/10.1159\/000324790.","journal-title":"Cells Tissues Organs"},{"key":"4832_CR11","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.7150\/thno.44309","volume":"10","author":"N Liu","year":"2020","unstructured":"Liu N, Zhang Z, Li L, Shen X, Sun B, Wang R, et al. MicroRNA-181 regulates the development of ossification of posterior longitudinal ligament via epigenetic modulation by targeting PBX1. Theranostics. 2020;10:7492\u2013509. https:\/\/doi.org\/10.7150\/thno.44309.","journal-title":"Theranostics"},{"key":"4832_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12551-018-0490-8","volume":"11","author":"Z Wang","year":"2019","unstructured":"Wang Z, Lachmann A, Ma\u2019ayan A. Mining data and metadata from the gene expression omnibus. Biophys Rev. 2019;11:103\u201310. https:\/\/doi.org\/10.1007\/s12551-018-0490-8.","journal-title":"Biophys Rev"},{"key":"4832_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bone.2008.05.016","volume":"44","author":"S-F Lei","year":"2009","unstructured":"Lei S-F, Wu S, Li L-M, Deng F-Y, Xiao S-M, Jiang C, et al. An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass. Bone. 2009;44:1010\u20134. https:\/\/doi.org\/10.1016\/j.bone.2008.05.016.","journal-title":"Bone"},{"key":"4832_CR14","doi-asserted-by":"publisher","first-page":"e45142","DOI":"10.1371\/journal.pone.0045142","volume":"7","author":"P Benisch","year":"2012","unstructured":"Benisch P, Schilling T, Klein-Hitpass L, Frey SP, Seefried L, Raaijmakers N, et al. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS ONE. 2012;7:e45142. https:\/\/doi.org\/10.1371\/journal.pone.0045142.","journal-title":"PLoS ONE"},{"key":"4832_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41598-018-19196-2","volume":"8","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Gao Y, Xu C, Shen H, Tian Q, Deng H-W. A novel approach for correction of crosstalk effects in pathway analysis and its application in osteoporosis research. Sci Rep. 2018;8:668. https:\/\/doi.org\/10.1038\/s41598-018-19196-2.","journal-title":"Sci Rep"},{"key":"4832_CR16","doi-asserted-by":"publisher","first-page":"18587","DOI":"10.1073\/pnas.0812334106","volume":"106","author":"Z Hamidouche","year":"2009","unstructured":"Hamidouche Z, Fromigu\u00e9 O, Ringe J, H\u00e4upl T, Vaudin P, Pag\u00e8s J-C, et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A. 2009;106:18587\u201391. https:\/\/doi.org\/10.1073\/pnas.0812334106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4832_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/scrt328","volume":"4","author":"F Langenbach","year":"2013","unstructured":"Langenbach F, Handschel J. Effects of dexamethasone, ascorbic acid and \u03b2-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther. 2013;4:117. https:\/\/doi.org\/10.1186\/scrt328.","journal-title":"Stem Cell Res Ther"},{"key":"4832_CR18","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1128\/MCB.00889-09","volume":"30","author":"JAR Gordon","year":"2010","unstructured":"Gordon JAR, Hassan MQ, Saini S, Montecino M, van Wijnen AJ, Stein GS, et al. Pbx1 represses osteoblastogenesis by blocking Hoxa10-mediated recruitment of chromatin remodeling factors. Mol Cell Biol. 2010;30:3531\u201341. https:\/\/doi.org\/10.1128\/MCB.00889-09.","journal-title":"Mol Cell Biol"},{"key":"4832_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/hmg\/ddn397","volume":"18","author":"C-L Cheung","year":"2009","unstructured":"Cheung C-L, Chan BYY, Chan V, Ikegawa S, Kou I, Ngai H, et al. Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation. Hum Mol Genet. 2009;18:679\u201387. https:\/\/doi.org\/10.1093\/hmg\/ddn397.","journal-title":"Hum Mol Genet"},{"key":"4832_CR20","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/jbmr\/zjaf099","volume":"40","author":"AG Pageau","year":"2025","unstructured":"Pageau AG, Burt LA, Gabel L, Boyd SK, Whittier DE. The association between physical activity during growth and bone microarchitecture at peak bone mass. J Bone Miner Res. 2025;40:1156\u201364. https:\/\/doi.org\/10.1093\/jbmr\/zjaf099.","journal-title":"J Bone Miner Res"},{"key":"4832_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00198-024-07250-x","volume":"36","author":"A Ghaseminejad-Raeini","year":"2025","unstructured":"Ghaseminejad-Raeini A, Azarboo A, Zareshahi N, Jalali S, Fallahtafti P, Homaei A, et al. Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis. Osteoporos Int. 2025;36:21\u201334. https:\/\/doi.org\/10.1007\/s00198-024-07250-x.","journal-title":"Osteoporos Int"},{"key":"4832_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11657-020-00822-4","volume":"15","author":"SN Morin","year":"2020","unstructured":"Morin SN, Berger C, Liu W, Prior JC, Cheung AM, Hanley DA, et al. Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos. 2020;15:147. https:\/\/doi.org\/10.1007\/s11657-020-00822-4.","journal-title":"Arch Osteoporos"},{"key":"4832_CR23","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.3892\/etm.2016.3857","volume":"12","author":"L Feng","year":"2016","unstructured":"Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, et al. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras\/MAPK signaling pathway. Exp Ther Med. 2016;12:3941\u20137. https:\/\/doi.org\/10.3892\/etm.2016.3857.","journal-title":"Exp Ther Med"},{"key":"4832_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbrc.2018.05.132","volume":"503","author":"S-N Wang","year":"2018","unstructured":"Wang S-N, Zhao X-Q, Yu B, Wang B-W. miR-193a inhibits osteogenic differentiation of bone marrow-derived stroma cell via targeting HMGB1. Biochem Biophys Res Commun. 2018;503:536\u201343. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.132.","journal-title":"Biochem Biophys Res Commun"},{"key":"4832_CR25","doi-asserted-by":"publisher","first-page":"116215","DOI":"10.1016\/j.bone.2021.116215","volume":"154","author":"Z Deng","year":"2022","unstructured":"Deng Z, Ren Y, Park MS, Kim HKW. Damage associated molecular patterns in necrotic femoral head inhibit osteogenesis and promote fibrogenesis of mesenchymal stem cells. Bone. 2022;154:116215. https:\/\/doi.org\/10.1016\/j.bone.2021.116215.","journal-title":"Bone"},{"key":"4832_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jcyt.2023.05.013","volume":"25","author":"Q Chang","year":"2023","unstructured":"Chang Q, Fujio M, Tsuboi M, Bian H, Wakasugi M, Hibi H. High-mobility group box 1 accelerates distraction osteogenesis healing via the recruitment of endogenous stem\/progenitor cells. Cytotherapy. 2023;25:946\u201355. https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.013.","journal-title":"Cytotherapy"},{"key":"4832_CR27","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1007\/s10528-023-10564-w","volume":"62","author":"K Pan","year":"2024","unstructured":"Pan K, Lu Y, Cao D, Peng J, Zhang Y, Li X. Long non-coding RNA SNHG1 suppresses the osteogenic differentiation of bone marrow mesenchymal stem cells by binding with HMGB1. Biochem Genet. 2024;62:2869\u201383. https:\/\/doi.org\/10.1007\/s10528-023-10564-w.","journal-title":"Biochem Genet"},{"key":"4832_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s13287-025-04543-8","volume":"16","author":"J Tang","year":"2025","unstructured":"Tang J, Li M, Huang L. HMGB1 as an emerging key modulator of bone remodeling: a narrative review. Stem Cell Res Ther. 2025;16:438. https:\/\/doi.org\/10.1186\/s13287-025-04543-8.","journal-title":"Stem Cell Res Ther"},{"key":"4832_CR29","doi-asserted-by":"publisher","first-page":"1569632","DOI":"10.3389\/fimmu.2025.1569632","volume":"16","author":"J Fan","year":"2025","unstructured":"Fan J, He K, Zhang Y, Li R, Yi X, Li S. HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases. Front Immunol. 2025;16:1569632. https:\/\/doi.org\/10.3389\/fimmu.2025.1569632.","journal-title":"Front Immunol"},{"key":"4832_CR30","doi-asserted-by":"publisher","first-page":"106070","DOI":"10.1016\/j.bbi.2025.106070","volume":"130","author":"Y-P Liang","year":"2025","unstructured":"Liang Y-P, Zhang D-Y, Le D-S, Liu L, Yang F, Sun S-Y, et al. Parylation dependent nuclear export of HMGB1 via exportin 1 contributes to morphine tolerance. Brain Behav Immun. 2025;130:106070. https:\/\/doi.org\/10.1016\/j.bbi.2025.106070.","journal-title":"Brain Behav Immun"},{"key":"4832_CR31","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1039\/c6tb00826g","volume":"4","author":"Y Lv","year":"2016","unstructured":"Lv Y, Lin C. High mobility group box 1-immobilized nanofibrous scaffold enhances vascularization, osteogenesis and stem cell recruitment. J Mater Chem B. 2016;4:5002\u201314. https:\/\/doi.org\/10.1039\/c6tb00826g.","journal-title":"J Mater Chem B"},{"key":"4832_CR32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/ph18071068","volume":"18","author":"SE Papapoulos","year":"2025","unstructured":"Papapoulos SE, Makras P. Bisphosphonates in the management of patients with postmenopausal osteoporosis; back to the future. Pharmaceuticals (Basel). 2025;18:1068. https:\/\/doi.org\/10.3390\/ph18071068.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4832_CR33","doi-asserted-by":"publisher","first-page":"1592184","DOI":"10.3389\/fphar.2025.1592184","volume":"16","author":"Y Man","year":"2025","unstructured":"Man Y, Na J, Wang H, Lan F, Yu L. Efficacy and safety of Jintiange in the treatment of osteoporosis: a systematic review and meta-analysis. Front Pharmacol. 2025;16:1592184. https:\/\/doi.org\/10.3389\/fphar.2025.1592184.","journal-title":"Front Pharmacol"},{"key":"4832_CR34","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.3390\/ijms26146924","volume":"26","author":"Z Gavrilov","year":"2025","unstructured":"Gavrilov Z, Lojk J. Rethinking osteoporosis drugs: can we simultaneously address sarcopenia? Int J Mol Sci. 2025;26:6924. https:\/\/doi.org\/10.3390\/ijms26146924.","journal-title":"Int J Mol Sci"},{"key":"4832_CR35","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1182\/blood-2012-06-435800","volume":"120","author":"Z Unnisa","year":"2012","unstructured":"Unnisa Z, Clark JP, Roychoudhury J, Thomas E, Tessarollo L, Copeland NG, et al. Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood. 2012;120:4973\u201381. https:\/\/doi.org\/10.1182\/blood-2012-06-435800.","journal-title":"Blood"},{"key":"4832_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood.2021013954","volume":"139","author":"Y Yang","year":"2022","unstructured":"Yang Y, Kueh AJ, Grant ZL, Abeysekera W, Garnham AL, Wilcox S, et al. The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal. Blood. 2022;139:845\u201358. https:\/\/doi.org\/10.1182\/blood.2021013954.","journal-title":"Blood"},{"key":"4832_CR37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/MCB.24.3.1256-1269.2004","volume":"24","author":"DB Sykes","year":"2004","unstructured":"Sykes DB, Kamps MP. E2a\/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol. 2004;24:1256\u201369. https:\/\/doi.org\/10.1128\/MCB.24.3.1256-1269.2004.","journal-title":"Mol Cell Biol"},{"key":"4832_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1677\/JOE-08-0085","volume":"198","author":"T Jin","year":"2008","unstructured":"Jin T. Mechanisms underlying proglucagon gene expression. J Endocrinol. 2008;198:17\u201328. https:\/\/doi.org\/10.1677\/JOE-08-0085.","journal-title":"J Endocrinol"},{"key":"4832_CR39","doi-asserted-by":"publisher","first-page":"e0328230","DOI":"10.1371\/journal.pone.0328230","volume":"20","author":"Y Fang","year":"2025","unstructured":"Fang Y, Jia Q, Dai Y, Li S. Decision aids in patients with osteoporosis: a scoping review. PLoS ONE. 2025;20:e0328230. https:\/\/doi.org\/10.1371\/journal.pone.0328230.","journal-title":"PLoS ONE"},{"key":"4832_CR40","doi-asserted-by":"publisher","first-page":"102840","DOI":"10.1016\/j.arr.2025.102840","volume":"111","author":"T-Y Guo","year":"2025","unstructured":"Guo T-Y, Deng J-H, Zhou Z-M, Chen J-Y, Zhou H-F, Zhang X, et al. Advancements in deep learning-based image screening for orthopedic conditions: emphasis on osteoporosis, osteoarthritis, and bone tumors. Ageing Res Rev. 2025;111:102840. https:\/\/doi.org\/10.1016\/j.arr.2025.102840.","journal-title":"Ageing Res Rev"},{"key":"4832_CR41","doi-asserted-by":"publisher","first-page":"102550","DOI":"10.1016\/j.arr.2024.102550","volume":"102","author":"E Ruggieri","year":"2024","unstructured":"Ruggieri E, Di Domenico E, Locatelli AG, Isopo F, Damanti S, De Lorenzo R, et al. HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases. Ageing Res Rev. 2024;102:102550. https:\/\/doi.org\/10.1016\/j.arr.2024.102550.","journal-title":"Ageing Res Rev"},{"key":"4832_CR42","doi-asserted-by":"publisher","first-page":"1579954","DOI":"10.3389\/fimmu.2025.1579954","volume":"16","author":"R Hollis","year":"2025","unstructured":"Hollis R, Tenet M, Aziz M, Wang P. Anti-DAMP therapies for acute inflammation. Front Immunol. 2025;16:1579954. https:\/\/doi.org\/10.3389\/fimmu.2025.1579954.","journal-title":"Front Immunol"},{"key":"4832_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12951-021-01077-y","volume":"19","author":"H Zheng","year":"2021","unstructured":"Zheng H, Liang X, Han Q, Shao Z, Zhang Y, Shi L, et al. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. J Nanobiotechnology. 2021;19:332. https:\/\/doi.org\/10.1186\/s12951-021-01077-y.","journal-title":"J Nanobiotechnology"},{"key":"4832_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10237-024-01900-z","volume":"24","author":"R Ruiz-Lozano","year":"2025","unstructured":"Ruiz-Lozano R, Calvo-Gallego JL, Pivonka P, Mart\u00ednez-Reina J. Optimisation of romosozumab plus denosumab sequential treatments against postmenopausal osteoporosis. insights from in silico simulations. Biomech Model Mechanobiol. 2025;24:383\u2013404. https:\/\/doi.org\/10.1007\/s10237-024-01900-z.","journal-title":"Biomech Model Mechanobiol"},{"key":"4832_CR45","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/cancers17111871","volume":"17","author":"H Jung","year":"2025","unstructured":"Jung H, Lee Y. Targeting the undruggable: recent progress in PROTAC-induced transcription factor degradation. Cancers (Basel). 2025;17:1871. https:\/\/doi.org\/10.3390\/cancers17111871.","journal-title":"Cancers (Basel)"},{"key":"4832_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183761","author":"N Zhang","year":"2025","unstructured":"Zhang N, Wang Q, Chen G, Liu L, Wang Z, Ma L, et al. Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI183761.","journal-title":"J Clin Invest"},{"key":"4832_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13:82. https:\/\/doi.org\/10.1038\/s41408-023-00853-3.","journal-title":"Blood Cancer J"},{"key":"4832_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ymthe.2024.03.001","volume":"32","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang C, Xia M, Tian Z, Zhou J, Berger JM, et al. Engineering small-molecule and protein drugs for targeting bone tumors. Mol Ther. 2024;32:1219\u201337. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.001.","journal-title":"Mol Ther"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04832-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:01:44Z","timestamp":1767099704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04832-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4832"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04832-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human bone marrow mesenchymal stem cells (hBMSCs) used in this study were obtained from commercial sources. According to the supplier\u2019s documentation, all cells were ethically derived with informed donor consent. The experimental protocols were reviewed and approved by the Ethics Committee of Xiangtan Central Hospital (Project Title: Role of PBX1 in skeletal stem cell senescence and fracture healing in the elderly; Approval No.: 2025JJ81137; Date of Approval: 2025-01-26). All procedures were performed in accordance with the Declaration of Helsinki and relevant institutional guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript, and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"695"}}